Daniel Mehnert
Daniel Mehnert
Haystack Oncology GmbH
Verified email at
Cited by
Cited by
Performance of Streck cfDNA blood collection tubes for liquid biopsy testing
I Medina Diaz, A Nocon, DH Mehnert, J Fredebohm, F Diehl, F Holtrup
PloS one 11 (11), e0166354, 2016
Detection and quantification of KIT mutations in ctDNA by plasma safe-SeqS
J Fredebohm, DH Mehnert, AK Löber, F Holtrup, V van Rahden, ...
Circulating Nucleic Acids in Serum and Plasma–CNAPS IX, 187-189, 2016
Broad spectrum of regorafenib activity on mutant KIT and absence of clonal selection in gastrointestinal stromal tumor (GIST): correlative analysis from the GRID trial
M Jeffers, C Kappeler, I Kuss, G Beckmann, DH Mehnert, J Fredebohm, ...
Gastric Cancer 25 (3), 598-608, 2022
Method for analyzing nucleic acid sequence
D Mehnert
US Patent 11,618,920, 2023
Method for analyzing nucleic acid sequence
D Mehnert
US Patent 11,608,525, 2023
Methods for detecting oncogenic mutations
J Fredebohm, F Diehl, F Holtrup, D Mehnert
US Patent 9,845,507, 2017
Performance assessment of highly sensitive NGS assay for TP53
J Fredebohm, D Mehnert, AK Löber, H Shimizu, F Holtrup, F Diehl
Cancer Research 76 (14_Supplement), 403-403, 2016
Identification of shared components of protein complexes
JP Pett, DH Mehnert, J Ibn-Salem, O Eigenbrod, R Otto, S Knorr, ...
The system can't perform the operation now. Try again later.
Articles 1–8